Comorbidity of asthma and diabetes: synergism or antagonism?
https://doi.org/10.18093/0869-0189-2014-0-6-103-107
Abstract
Asthma is a chronic inflammatory disease with the growing prevalence over the last 50 years. Some endocrine disorders including diabetes mellitus and obesity were identified as important factors affecting asthma course. Currently, controversial data on probable role of Th2-imbalance for pathogenesis of type 2 diabetes mellitus have been published. Diabetes and asthma could have similar pathogenic mechanisms which are poorly understood. There is a lack of Russian publications on this problem. Comorbidity of asthma and diabetes could be synergic or antagonistic. Conclusion. Further investigations of comorbidity of asthma and diabetes is necessary.
About the Authors
V. A. Ivanov
State Institution "Academician I.P.Pavlov First Saint-Petersburg State Medical University", Federal Agency on Healthcare and Social Development of Russia: 6 / 8, L'va Tolstogo ul., Saint-Petersburg, 197022, Russia
Russian Federation
Russian Federation
PhD student, Acad. M.V.Chernorutskiy Chair of Hospital Therapy, State Budget High-Level Educational Institution "Academician I.P.Pavlov First Saint-Petersburg State Medical University", Federal Agency on Healthcare and Social Development of Russia; tel.: (921) 883-99-90
L. N. Sorokina
State Institution "Academician I.P.Pavlov First Saint-Petersburg State Medical University", Federal Agency on Healthcare and Social Development of Russia: 6 / 8, L'va Tolstogo ul., Saint-Petersburg, 197022, Russia
Russian Federation
Russian Federation
MD, Associate Professor, Acad. M.V.Chernorutskiy Chair of Hospital Therapy, State Budget High-Level Educational Institution "Academician I.P.Pavlov First Saint-Petersburg State Medical University", Federal Agency on Healthcare and Social Development of Russia; tel.: (921) 403-90-35
V. N. Mineev
State Institution "Academician I.P.Pavlov First Saint-Petersburg State Medical University", Federal Agency on Healthcare and Social Development of Russia: 6 / 8, L'va Tolstogo ul., Saint-Petersburg, 197022, Russia
Russian Federation
Russian Federation
MD, Professor, Acad. M.V.Chernorutskiy Chair of Hospital Therapy, State Budget High-Level Educational Institution "Academician I.P.Pavlov First Saint-Petersburg State Medical University", Federal Agency on Healthcare and Social Development of Russia; tel.: (921) 359-62-95
N. E. Shestakova
State Institution "Academician I.P.Pavlov First Saint-Petersburg State Medical University", Federal Agency on Healthcare and Social Development of Russia: 6 / 8, L'va Tolstogo ul., Saint-Petersburg, 197022, Russia
Russian Federation
Russian Federation
the 6th year student, State Budget HighLevel Educational Institution "Academician I.P.Pavlov First Saint-Petersburg State Medical University", Federal Agency on Healthcare and Social Development of Russia; tel.: (981) 714-18-86
A. A. Bystrova
State Institution "Academician I.P.Pavlov First Saint-Petersburg State Medical University", Federal Agency on Healthcare and Social Development of Russia: 6 / 8, L'va Tolstogo ul., Saint-Petersburg, 197022, Russia
Russian Federation
Russian Federation
PhD, Assistant Lecturer, G.F.Lang Chair of Faculty Therapy, State Budget High-Level Educational Institution "Academician I.P.Pavlov First Saint-Petersburg State Medical University", Federal Agency on Healthcare and Social Development of Russia; tel. (812) 9571677
V. I. Trofimov
State Institution "Academician I.P.Pavlov First Saint-Petersburg State Medical University", Federal Agency on Healthcare and Social Development of Russia: 6 / 8, L'va Tolstogo ul., Saint-Petersburg, 197022, Russia
Russian Federation
Russian Federation
MD, Professor, Acad. M.V.Chernorutskiy Chair of Hospital Therapy, State Budget High-Level Educational Institution "Academician I.P.Pavlov First Saint-Petersburg State Medical University", Federal Agency on Healthcare and Social Development of Russia; tel.: (812) 234-54-51
References
1. Lowder T.W., Kunz H.E. Regulatory T cells in asthma and airway hyperresponsiveness. J. Allergy Ther. 2011; Suppl. 1: 1–8.
2. Karlstad O., Nafstad P., Tverdal A. et al. Comorbidities in an asthma population 8–29 years old: a study from the Norwegian Prescription Database. Pharmacoepidemiol. Drug. Saf. 2012; 21: 1045–1052.
3. Shi H.N., Walker W.A. T helper cell subclasses and clinical disease states. Curr. Opin. Gastroenterol. 2002; 18: 711–716.
4. Минеев В.Н. Концепция бронхиальной астмы как мембрано-рецепторной патологии. Иммунопатология, аллергология, инфектология. 2005; 3: 68–85. / Mineev V.N. An approach to bronchial asthma as to membrane and receptor pathology. Immunopatologiya, allergologiya, infektologiya. 2005; 3: 68–85 (in Russian).
5. Vianna E.O., Garcia-Leme J. Allergen-induced airway inflammation in rats. Role of insulin. Am. J. Respir. Crit. Care. Med. 1995; 151: 809–814.
6. Insuela D.B.R., Silva P.M.R., Martins M.A., Carvalho V.F. The Yin Yang of hormones that control glucose homeostasis in asthma. J. Allergy Ther. 2013; 11: 3–8.
7. Колычев А.П., Минеев В.Н., Булатова Н.Ю., Федосеев Г.Б. Особенности инсулин-рецепторных взаимодействий при бронхиальной астме. Пульмонология. 1994; 2: 48–51. / Kolychev A.P., Mineev V.N., Bulatova N.Yu., Fedoseev G.B. Insulin-receptor interactions in bronchial asthma. Pul'monologiya. 1994; 2: 48–51 (in Russian).
8. Hashemzadeh M., Movahed M.R. The occurrence of asthma in hospitalized patients with type 2 diabetes mellitus. Intern. Med. J. 2009; 39 (10): 699–701.
9. Sheiner E., Mazor M., Levy A. et al. Pregnancy outcome of asthmatic patients: a population-based study. J. Matern. Fetal Neonat. Med. 2005; 18: 237–40.
10. Rapaport M.J., Bistritzer T., Aharoni D. Th1/Th2 cytokine secretion of first degree relatives of T1DM patients. Cytokine. 2005; 30 (5): 219–227.
11. Кононенко И.В., Прокофьев С.А., Смирнова О.М. Функциональное состояние β-клеток, иммунологические и клинико-биохимические характеристики у больных с медленно прогрессирующим аутоиммунным диабетом взрослых. Проблемы эндокринологии. 2004; 50 (1): 18–22. / Kononenko I.V., Prokof'ev S.A., Smirnova O.M. Functional status of β-cells and immunological, clinical and biochemical features of adult patients with slowly-progressive autoimmune diabetes mellitus. Problemy endokrinologii. 2004; 50 (1): 18–22 (in Russian).
12. Саприна Т.В., Лазаренко Ф.Э., Прохоренко Т.С. и др. Роль Th1/Th2 дисбаланса иммунного ответа в детерминации клинических особенностей аутоиммунного сахарного диабета взрослых. Сахарный диабет. 2011; 2: 12–17. / Saprina T.V., Lazarenko F.E., Prokhorenko T.S. et al. A role of Th1/Th2 immune imbalance for clinical course of diabetes mellitus in adults. Sakharnyy diabet. 2011; 2: 12–17 (in Russian).
13. Brealey D., Singer M. Hyperglycemia in critical illness: a review. J. Diabet. Sci. Technol. 2009; 3: 1250–1260.
14. McMahon G.T., Arky R.A. Inhaled insulin for diabetes mellitus. N. Engl. J. Med. 2007; 356: 497–502.
15. Минеев В.Н., Булатова Н.Ю. Особенности влияния ингаляций глюкозы на реактивность бронхов при бронхиальной астме. Клиническая медицина. 2001; 79 (8): 37–39. / Mineev V.N., Bulatova N.Yu. An influence of inhalational glucose on bronchial reactivity in patients with asthma. Klinicheskaya meditsina. 2001; 79 (8): 37–39 (in Russian).
16. Viardot A., Grey S.T., Mackay F., Chisholm D. Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology. 2007; 148: 346–353.
17. Shore S.A., Schwartzman I.N., Mellema M.S. et al. Effect of leptin on allergic airway responses in mice. J. Allergy Clin. Immunol. 2005; 115: 103–109.
18. Giannessi D., Maltinti M., Del Ry S. Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk. Pharmacol. Res. 2007; 56: 459–467.
19. Shore S.A., Terry R.D., Flynt L. et al. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J. Allergy Clin. Immunol. 2006; 118: 389–395.
20. Sherman M.S., Lazar E.J., Eichacker P. A bronchodilator action of glucagon. J. Allergy. Clin. Immunol. 1988; 81: 908–911.
21. Imbruce R., Goldfedder A., Maguire W. et al. The effect of glucagon on airway resistance. J. Clin. Pharmacol. 1975; 15: 680–684.
22. Olsen P.C., Coelho L.P., Costa J.C. et al. Two for one: cyclic AMP mediates the anti-inflammatory and anti-spasmodic properties of the non-anesthetic lidocaine analog JMF2-1. Eur. J. Pharmacol. 2012; 680: 102–107.
23. Hu C.P., Zou Y.Q., Feng J.T., Li X.Z. The effect of unilateral adrenalectomy on transformation of adrenal medullary chromaffin cells in vivo: a potential mechanism of asthma pathogenesis. PLoS One. 2012; 7: e44586.
24. Scola A.M., Loxham M., Charlton S.J., Peachell P.T. The long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells. Br. J. Pharmacol. 2009; 158: 267–276.
25. Goleva E., Dunlap A., Leung D.Y. Differential control of TH1 versus TH2 cell responses by the combination of lowdose steroids with beta2-adrenergic agonists. J. Allergy Clin. Immunol. 2004; 114: 183–191.
26. Giordano R., Guaraldi F., Berardelli R. et al. Glucose metabolism in patients with subclinical Cushing's syndrome. Endocrine. 2012; 41: 415–423.
27. Torres R.C., Insuela D.B.R., Carvalho V.F. Mecanismos celulares e moleculares da acao antiinflamatoria dos glicocorticoides. Corpus et Scientia. 2012; 8: 36–51.
28. Maneechotesuwan K., Yao X., Ito K. et al. Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease. PLoS Med. 2009; 6: e1000076.
29. Ammit A.J., Burgess J.K., Hirst S.J. et al. The effect of asthma therapeutics on signalling and transcriptional regulation of airway smooth muscle function. Pulm. Pharmacol. Ther. 2009; 22: 446–454.
30. Barnes P.J. Biochemical basis of asthma therapy. J. Biol. Chem. 2011; 286: 32899–32905.
31. Rajala M.W., Obici S., Scherer P.E., Rossetti L. Adiposederived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J. Clin. Invest. 2003; 111: 225–230.
32. Condliffe A.M., Cadwallader K.A., Walker T.R. et al. Phosphoinositide 3-kinase: a critical signalling event in pulmonary cells. Respir. Res. 2000; 1: 24–29.
33. Федосеев Г.Б., Трофимов В.И., Петрова М.А., ред. Многоликая бронхиальная астма, диагностика, лечение и профилактика. СПб: Нордмед-Издат; 2011. / Fedoseev G.B., Trofimov V.I., Petrova M.A., eds. Multifaced Bronchial Asthma: Diagnosis, Treatment, Prevention. St-Petersburg: Nordmed-Izdat; 2011 (in Russian).
Review
For citations:
Ivanov V.A., Sorokina L.N., Mineev V.N., Shestakova N.E., Bystrova A.A., Trofimov V.I. Comorbidity of asthma and diabetes: synergism or antagonism? PULMONOLOGIYA. 2014;(6):103-107. (In Russ.) https://doi.org/10.18093/0869-0189-2014-0-6-103-107
Views:
5833
Email this article 